Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bricanyl Turbuhaler M3 versus M2 methacholine bronchoprotection study in stable asthma
NL-OMON42299Phase 3Active, not recruiting
- Sponsor
- AstraZeneca
- Start
- Apr 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of terbutaline in asthma (4 arms), sponsored by AstraZeneca. Primary endpoint: PC20. Started Apr 2015; status: active, not recruiting.
02
Drugs
terbutaline
03
Conditions
asthma
Beyond the preview
Go deeper on NL-OMON42299.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON42299.